Replies to post #3067 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

IDIX Insider Shareholdings

[Updated for Form-4 filings through 12/17/09. Options
listed below include both vested and non-vested holdings.]

 
 Executive Officers  
 JP Sommadossi, CEO       2,220K shares  1,806 options 
 Ron Renaud, CFO             15K shares   455K options 
 Doug Mayers, CMO            30K shares   260K options 
 David Standring, EVP Bio    68K shares   100K options 
 John Weidenbruch, Gen Cnsl  35K shares   275K options 
 Paul Fanning, SVP HR         1K shares    70K options 
 -- 
 Six executive officers   2,369K shares 2,966K options 

 
 Independent directors  
 Charles Cramb                7K shares   140K options 
 Wayne Hockmeyer             42K shares   100K options 
 Thomas Hodgson              92K shares   100K options 
 Denise Pollard-Knight         0 shares    80K options 
 Pamela Thomas-Graham          0 shares   115K options 
 -- 
 Five independent dirctrs   141K shares   535K options 

 
 All officers/directors   2,510K shares 3,501K options